ArticlePDF Available

Abstract

Anemia is the commonest hematological disorder that occurs in pregnancy. According to the recent standard laid down by ‘WHO’, anemia is present when the Hemoglobin (Hb) concentration in the peripheral blood is 11 gm/dl or less. The most common cause of anemia in pregnancy is lack of iron. Less often, it is caused by folic acid deficiency. In some populations, 80% of pregnant women are anemic. Those most at risk are women from low socio-economic groups and teenagers. Anemia is diagnosed by estimating the hemoglobin concentration and examining a peripheral blood smear for the characteristic red blood cell changes. Iron and folate supplementation is indicated during pregnancy to prevent the complications. DOI: http://dx.doi.org/10.3329/medtoday.v26i1.21314 Medicine Today 2014 Vol.26(1): 49-52
2014 Volume 26 Number 01 49
Abstract
Anemia is the commonest hematological disorder that
occurs in pregnancy. According to the recent standard laid
down by ‘WHO’, anemia is present when the Hemoglobin
(Hb) concentration in the peripheral blood is 11 gm/dl or
less. The most common cause of anemia in pregnancy is
lack of iron. Less often, it is caused by folic acid deciency.
In some populations, 80% of pregnant women are anemic.
Those most at risk are women from low socio-economic
groups and teenagers. Anemia is diagnosed by estimating the
hemoglobin concentration and examining a peripheral blood
smear for the characteristic red blood cell changes. Iron
and folate supplementation is indicated during pregnancy to
prevent the complications.
Key words : Erythropoiesis, Puerperium, APH, PPH, ANC,
LBW, IUD.
Introduction
Anemia is a lack of functioning red blood cells (RBCs) that
leads to a lack of oxygen-carrying ability, causing unusual
complications during life time1. These RBCs are produced in
the bone marrow. They have a life expectancy of about 120
days. Among other things, the body needs iron, vitamin B12 &
folic acid for erythropoiesis. If there is a lack of one or more
of these ingredients or there is an increased loss of RBCs,
anemia develops. Any patient with a Hb of less than 11
gm/dl to 11.5 gm/dl at the start of pregnancy will be treated
as anemic. The reason is that as the pregnancy progresses,
the blood is diluted and the woman will eventually become
anemic. The dilution of blood in pregnancy is a natural
process and starts at approximately at the eighth week of
pregnancy and progresses until the 32nd to 34th week of
pregnancy2.
Incidence
In tropical countries, the incidence of anemia3 in pregnancy
is about 40-80%.
In developed countries, it ranges between 10-20%.
It is responsibe for 20% of maternal death in developing
countries.
Classication of anemia in pregnancy
Grossly classied into two types4:
(A) Pathological anemia in pregnancy.
(B) Physiological anemia in pregnancy.
(A) Pathological Anemia is further sub-classied into
1. Deciency Anemia, e. g.,
-Iron deciency
-Folic acid deciency
-B12 deciency
-Protein deciency
2. Hemorrigic:
Acute hemorrhagic: Following bleeding in early month of
pregnancy or APH
Chronic hemorrhagic: as by hookworm infestation, GI
(gastrointestinal) bleeding.
1. Hereditary:
Thalassemias – Haemolobinopathies.
Hereditary hemolytic anemia – RBCs defects.
2. Bone Marrow insufciency: as by radiation, marrow
suppressant drugs.
3. Anemia of infection – as by malaria tuberculosis
4. Chronic diseases : as in nephropathies & neoplastic
disorders.
It is noteworthy that obstetricians are concerned with two
common types of anemia. They are :
5. Deciency anemia,
6. Haemorrhagic anemia
It has been found there is increased prevalence of anemia in
pregnancy in tropical countries.
This is due to
a. Faulty dietary habit,
b. Faulty absorption mechanism,
c. More iron loss due to sweating and repeated pregnancy
at short interval; prolonged period of lactation,
d. Infection : Chronic malaria, tuberculosis,
e. Excess demand of iron : pregnancy is an iron decit
state.
(B) Physiological Anemia
During pregnancy there is disproportionate increase in
plasma volume upto 50%, RBC 33% and Hb 18-20% mass.
In addition there is marked demand of extra iron during
Anemia in Pregnancy
Chowdhury S1, Rahman M2, Moniruddin ABM3
1. Corresponding Author: Salma Chowdhury MBBS, DGO
Senior Consultant (Gynae)
Central Police Hospital, Rajarbag, Dhaka
Email: dr.salmachowdhury@yahoo.com
2. Mizanur Rahman MBBS, FCPS
Associate Professor of Surgery
Faridpur Medical College, Faridpur
3. ABM Moniruddin MBBS, FCPS
Professor of Surgery
City Medical College, Itahata, Gazipur
Review Article
2014 Volume 26 Number 01
50
REVIEW ARTICLE
pregnancy especially in the second half of pregnancy.
So, physiological anemia is due to combined effect of
hemodialution & negative iron balance.
Criteria of Physiological Anemia include5
- Hb% - 10 gm r less,
- R.B.C – 3.5 million/mm3,
- P.C.V – 30%,
- PBF – Normal morphology with central pallor.
Clinical features of iron deciency Anemia depends more on
the degree of anemia. Symptoms of anemia include lassitude,
feeling of exhaustion, weakness, anorexia, indigestion,
palpitation, swelling legs Signs of anemia include pallor,
glossitis, Stomatitis, edema legs, soft systolic murmur in
mitral area. Investigations are done to detect the degree of
anemia, the type of anemia the cause of anemia.
To ascertain the degree of anemia one must look for Hb%,
RBC count, PCV (Packed Cell Volume). Mild anemia means
Hb- 8-10 gm%; Moderate- less than 7-8 gm%; Severe – Less
than 7 gm%.
To determine type of anemia one must examine the PBF
(Peripheral Blood Film), hematological indcies like MCV,
MCH, MCHC, etc.
A typical iron deciency anemia shows the owing blood
values:
- Hb-less than 10 gm%
- RBC – less 4 million/ mm3
- PCV – less than 30%
- MCHC – Less than 30%
- MCV – less than 75% micro mole m3 (meter cube)
- MCH- less than 25 pg.
Serum iron is usally below 30 micro gram/ 100 ml. Total iron
binding capacity increases to 400 micro gram/100ml. Serum
ferritin falls below 15 micro gm/L.
To nd out the cause of anemia, the physician should
carefully follow the basic protocols.
- History taking,
- Physical examination,
- Routine examination of stool to detect helminthes or
occult blood,
- Urine is examined for the protein, sugar and pus cells,
- X ray chest in suspected cases of pulmonary tuberculosis;
but in case not responding to therapy, bone marrow study
should be undertaken.
- Blood for PBF & malarial parasites,
- Kidney function tests like BUN & s. creatinine, etc.
Differential Diagnosis of deciency anemias in
pregnancy:6
- Infection,
- Nephritis,
- Hemoglobinnopathies.
Treatment of anemia in Pregnancy:7
- Prophylactic
- Curative Prophylaxis includes
- Avoidance of frequent child birth by proper family
planning method.
Dietary prescription: Realistic balanced diet rich in iron and
portion like liver, meat, eggs, green vegetable etc. Adequate
treatment should be instituted to eradicate hook worm
infestation, control of dysentery, malaria, nephropathies &
excision of bleeding piles. Hb level should be estimated at
the 1st ANV and 30th and nally at 36th week.
Curative treatment:
- Hospitalisation, if Hb level is below 7.5 gram percent.
General treatment:
- Diet – balanced diet rich in protein, vitamins and iron
- Antibiotic for infective focuses, if any.
Specic Therapy as needed:
- Oral,
- Parental,
- Blood transfusion.
Depending on
- Severity of anemia,
- Duration of pregnancy,
- Associate complicating factor.
Iron Therapy:
Parenteral –
1. Intravenous,
a. Total dose infusion,
b. Multidose infusion,
2. Intramuscular:
- Iron dexran,
- Iron sorbital.
Estimation of total requirement:
0.3 X W ( 100-Hb%) gm of elemental iron + addition of 50%.
Improvement is expected withon 3-4 weeks.
Advantage of blood transfusion:8
- Increased O2 carrying capacity,
- Hb from heamolysed RBC,
- Stimulating by erythropoietin,
2014 Volume 26 Number 01 51
REVIEW ARTICLE
- Supplies natural content of blood antibodies,
- Improvement is expected after 3 days.
Precaution:
- To prevent circulatory over load,
- Antihistamine for allergic episodes,
- Diuretic injection 20 mg Frusemide,
- Careful observation of respiration & crepitations at the
lung bases.
Place of blood transformation :
Indications:
- To correct blood loss,
- To combat PPH,
- Beyond 36 weeks and severe anemia, refectory anemia.
Quality and quantity of blood:
- Fresh and properly typed, grouped and cross matched;
only PCV are transfused.
- Quantity 80-100 ml at a time interval after 24 hours for
circulating readjustment.
Complications of severe anemia:9
During pregnancy-
- Pre-eclampisa,
- Recurrent infection,
- Heart failure,
- Preterm labour,
During labor-
- Uterine inertia,
- PPH,
- Cardiac failure,
- Shock.
During puerperium:
- Puerperal sepsis,
- Sub-involution,
- Failing lactation.
Management during labor:
In 1st stage-
- Patient. should be in bed and should be in a position
comfortable to her,
- Arrangement for oxygen,
- Aseptic condition is to me maintained.
In 2nd stage-
- Prophylactic low force/ vacuum delivery.
In 3rd stage-
- Active management.
Prophylactic antibiotic to prevent infection
- Iron therapy for at least 3 months following delivery.
Risk periods:
- At 30-32 weeks of pregnancy,
- During labor,
- Immediately following delivery.
Prognosis:10
Maternal aspect-
1. If detected early & proper treatment is instituted, anemia
improves promptly;
2. Substantial chances of recurrence in next pregnancy,
3. Contributes to about 2-% maternal death in developing
countries.
Fetal aspects-
- Baby born at term from severely anemic mother will not
be anemic at birth. But there is little or no reserved iron.
So anemia develops at neonatal period,
- Preterm labour,
- LBW (Low Birth Weight),
- IUD (Intra-Uterine Death).
Discussion
The most common cause of anemia in pregnancy is iron
deciency. It usually occurs due to low iron stores prior to
pregnancy. The growing fetus depletes what stores there are
and takes priority for any iron available. It is important to
remember that increased iron requirements continue after the
birth of the baby due to blood loss and breastfeeding. Less
often, anemia in pregnancy is caused by folic acid deciency.
In certain populations, pregnancy can be complicated
by sickle cell trait and anemia, as well as thalassaemias11.
These diseases, in which the red blood cells are abnormal,
present special problems in pregnancy. In some populations,
as many as 80% of pregnant women are anemic. They are
generally women from lower socio-economic groups in
developing countries as well as pregnant teenagers. Women
who experienced heavy periods and those who became
pregnant soon after the birth of a child are at particular risk
of becoming anemic in pregnancy. The symptoms such as
tiredness and general weakness will be similar to those of
any other type of anemia. In severe cases, the woman will
be short of breath even at rest. If the anemia is prolonged,
other signs of iron-deciency anemia may develop such
as a smooth shiny tongue and tenderness of the skin at the
corners of the mouth. However, these advanced signs are
rare. The diagnosis is made by examining a full blood count
and noting the low hemoglobin concentration as well as the
characteristic small, pale red blood cells under the microscope
(in the case of iron deciency anemia). The diagnosis of
iron deciency anemia can be conrmed by measuring the
2014 Volume 26 Number 01
52
REVIEW ARTICLE
amount of storage iron as well as the levels of iron binding
proteins in the blood. The diagnosis of folate deciency is
conrmed by estimating the red blood cell folate levels. If the
anemia does not respond to iron treatment, additional folic
acid deciency should be suspected. A well balanced diet is
always recommended but iron and folate supplementation is
indicated in pregnancy. When the anemia is caused by lack
of iron, it is treated with iron supplements, preferably ferrous
sulphate tablets (300mg). These supplements should not be
taken more than twice daily, since the side effects of iron are
increased in doses of more than two daily. The side effects
are stomach upsets and constipation which are problematic
in pregnancy12. If the anemia is due to folic acid deciency, it
is treated with folic acid supplements (1 to 5 mg once a day).
As long as the anemia is treated and corrected, there should
be no problem.
In majority cases, the management of anemia in pregnancy is
easy & worthwhile if the pregnant women & their guardians
remain alert to protect the health of mother & baby. They need
to ensure proper antenatal check up, perinatal & postnatal
cares & follow relevent medical advice.
All pregnant women should be fully assessed at the start of
their pregnancy so that any problems such as anemia will be
picked up and treated.
References
1. Centres for Disease Control and Prevention.
Recommendations to Prevent and Control Iron
Deciency in the United States. Morbidity and Mortality
Weekly Report. 1998;47(No. RR-3)
2. Breymann C, Bian X, Blanco-Capito LR, et al. Expert
recommendations for the diagnosis and treatment
of iron-deciency anemia during pregnancy and the
postpartum period in the Asia-Pacic region. Journal of
Perinatal Medicine. 2010;38:1-8.
3. Milman N. Prepartum anaemia: prevention and
treatment. Annals of Haematology. 2008;87:949-59.
4. Reveiz L, Gyte GMI, Cuervo LG. Treatments for
iron-deciency anaemia in pregnancy. The Cochrane
Database of Systematic reviews. 2007(2).
5. Johnson TA. Anaemia. In: Luesley DM, Baker PN,
editors. Obstetrics and Gynaecology An evidence-based
text for MRCOG 2nd ed. London: Hodder Arnold;
2010;139-43.
6. Pavord S,Myers B, Robinson B, Allard S, Strong J,
Oppenheimer C. UK guidelines on the management
of iron deciency in pregnancy. Br J Haematol.
2012;156:588-600.
7. South Australian Perinatal Practice Guidelines Chapter
60 Anaemia in pregnancy. South Australia [Updated
2012 May 22; cited 2013 December 17]. Available
from:http://www.health.sa.gov.au/ppg/Default.
aspx?tabid=95
8. Milman N. Iron and pregnancy -a delicate balance.
Annals of Hematology. 2006;85:559-65.
9. Pasricha SRS, Flecknoe-Brown SC, Allen KJ, et al.
Diagnosis and management of iron deciency anaemia:
a clinical update. MJA. 2010;193:525-32.
10. The American College of Obstetricians and
Gynecologists. ACOG Practice Bulletin No. 95 Anemia
in Pregnancy. Obstetrics & Gynecology. 2008;112:201-
7.
11. Bryant C, Larsen S. Anaemia in pregnancy. The
Australian and New Zealand Journal of Obstetrics and
Gynaecology. 2009;11:17-8.
12. Simpson JL, Bailey LB, Pietrzik K, et al. Micronutrients
and women of reproductive potential: required dietary
intake and consequences of dietary deciency or excess.
Part 1 -Folate, Vitamin B12, Vitamin B6. J Matern Fetal
Neonatal Med. 2010;23:1323-43.
... Signs of anaemia include pallor, glossitis, Stomatitis, edema legs, soft systolic murmur in mitral area. Investigations are done to detect the degree of anaemia, the type of anaemia, the cause of anaemia.11 The symptoms of anaemia are as follows ...
Article
Full-text available
Anaemia is a most common disorder of Indian women especially during the age of reproduction. Anaemia in pregnancy is a condition with effects that may deleterious to mothers and foetus. Indeed, it is a known risk factor for maternal and leads to foetal complications. However, women are much better aware now about their pregnancy related conditions than they were years ago. This is not just a feminist fad but common sense for the woman who knows what is likely to happen and will be better prepared for actions in pregnancy. The WHO considers iron deficiency to the largest International nutritional disorder. According to WHO anaemia in pregnancy is present when the concentration of haemoglobin in the peripheral blood is 11gms/100ml or less. As per American college of obstetrician and gynaecologist 60-100mgs of elemental iron per day prevents iron deficiency in a pregnant woman. In Unani system of medicine number of drugs and diets are available which have preventive and therapeutic role. Unani physicians paid special attention to child and mother care in general as well as in pregnancy. Natural medicines are economical, easily available and relatively free of side effects. So, the present topic highlights the use of Unani medicines providing iron supplements in the treatment of early and late pregnancy. Keywords: Anaemia, Pregnancy, Foetal complications, Unani medicine
... Another complication of anaemia during pregnancy that still not familiar is breastfeeding failure. However, an article review mentioned breastfeeding failure becoming the impact of anaemia during pregnancy, after puerperal sepsis and subinvolution [15]. ...
Article
Full-text available
BACKGROUND: The prevalence of anaemia is higher among women, including pregnant women. The estimation was about 24.8% of the population in the world suffering anaemia. Anaemia during pregnancy is a big problem because it can contribute morbidity and mortality, either in mother or newborn. The impacts of anaemia during pregnancy included post-partum haemorrhage, low birth weight (LBW), preterm delivery, and low Appearance, Pulse, Grimace, Activity, Respiration (APGAR) score. AIM: This study aimed to determine the correlation between haemoglobin concentration during pregnancy and the outcome of mothers and newborns. METHODS: It was a cohort study that included 200 pregnant women in second or third trimester at antenatal care of Sundari General Hospital Outpatient Clinic on February until September 2018. The participants were interviewed using a questionnaire, and their blood was checked to measure haemoglobin concentration using portable Easy Touch Hemoglobinometer. In the next three until six months, the following investigation was conducted to assess the maternal and neonatal outcome. RESULTS: The result of this study showed among the maternal outcome, only antepartum haemoglobin concentration had a statistically significant correlation with the haemoglobin concentration during pregnancy (p < 0.05), meanwhile, among the neonatal outcome. LBW was the only factor that statistically significantly correlated to the haemoglobin concentration during pregnancy (p < 0.05). CONCLUSION: We can conclude that once anaemia occurs in pregnant women, then the women kept suffering from anaemia with its correlation was statistically significant. Keywords : hemoglobin concentration, anemia during pregnancy, maternal, neonatal outcome
Article
Full-text available
Bu çalışmada genç ve ileri yaş maternal aneminin plasenta dokusunda beyin-türevli nörotrofik faktör (BDNF) ve sinir büyüme faktörü (NGF) düzeyleri üzerinde etkili olup olmadığının belirlenmesi amaçlanmıştır. Araştırma kapsamındaki gebelerin, anemi durumlarına göre; 1- 18 yaş altı anemik gebeler (çalışma grubu) (n: 30), 2- 35 yaş üstü anemik gebeler (çalışma grubu) (n: 36), 3- 18 yaş altı anemik olmayan gebeler (kontrol grubu) (n: 30), 4- 35 yaş üstü anemik olmayan gebeler (kontrol grubu) (n: 39), olmak üzere 4 grupta yürütülmüştür. Alınan plasenta dokuları immünohistokimya tekniği uygulaması için fiksatife alınmıştır. Plasental BDNF ve NGF düzeylerine bakılmıştır. BDNF immün boyamasında 18 yaş altı anemik ve anemik olmayan grupta sinsityotrofoblast ve stromal hücrelerde zayıftan ortaya değişen reaksiyon izlendi. 35 yaş üstü anemik grupta da zayıftan ortaya değişen ekspresyon izlenirken, 35 yaş üstü anemik olmayan grupta sinsityotrofoblast ve stromal hücrelerde kuvvetli reaksiyon dikkati çekti. NGF immün boyamasında 18 yaş altı anemik grupta sinsityotrofoblast hücrelerinde zayıf reaksiyon izlenirken, 18 yaş altı anemik olmayan grupta sinsityotrofoblast hücrelerde ve stromada ise kuvvetli immün reaksiyon izlendi. 35 yaş üstü anemik grupta ortadan kuvvetliye değişen reaksiyon izlenirken, 35 yaş üstü anemik olmayan grupta sinsityotrofoblast hücrelerde ve stromada oldukça kuvvetli ekspresyon dikkati çekti. Plasentada BDNF ekspresyon düzeyi anemisi olan genç gebelerde daha yüksek etkili iken, NGF ekspresyon düzeyi anemisi olan genç gebelerde düşük olduğu görülmüştür. Anemisi olmayan ileri yaş grup gebelerde nörotrofinler (BDNF ve NGF) daha yüksek iken, ileri yaş anemik gebelerde düşüktür. Aneminin ileri yaş gruplarında plasentadaki nörotrofinleri baskıladığı görülmektedir. Maternal anemi yeni doğan merkezi sinir sisteminde etkilidir. Clinical trials numarası NCT03893084.
Article
Full-text available
Background Anaemia has become a major public health concern among women in Sub-Saharan Africa (SSA). However, little is known about the spatial disparities in anaemia prevalence and their associated factors among pregnant women in the region. This study analysed the spatial disparities in anaemia and their associated factors among pregnant women in rural and urban settings in SSA. Methods This is a secondary analysis of the most recent demographic and health surveys of 26 countries in SSA. Spatial autocorrelation and hotspot assessment were conducted, while a multivariate logistic regression model was used to identify demographic factors associated with anaemia. Results Anaemia was reported among ~50% of pregnant women in urban and rural areas of SSA. The hotspot analysis identified the West African sub-region as having a higher concentration of anaemia cases in rural settings. In urban areas, the odds of anaemia were significantly higher among pregnant women in their second trimester (Adjusted OR = 2.39, CI = 1.99, 2.76). On the other hand, pregnant women in their third trimester (Adjusted OR = 1.98, CI = 1.77, 2.22) and those who had taken intestinal parasite drugs (Adjusted OR = 1.12 CI = 1.02, 1.23) had a higher likelihood of having anaemia in rural areas. Pregnant women aged 35–39 years (Adjusted OR = 0.52, CI = 0.33, 0.81) and those aged 40–44 years (Adjusted OR = 0.69, CI = 0.50, 0.95) had a lesser likelihood of having anaemia compared to women aged 15–19 years in urban and rural areas respectively. Compared to Congo DR, Benin (OR = 2.22, CI = 1.51, 3.28) and Mali (OR = 3.71, CI = 2.73, 5.05) had higher odds of anaemia in urban and rural areas respectively. Conclusions Spatial disparities in anaemia persist among pregnant women in rural and urban settings in SSA. Prevailing spatial variations in anaemia may be addressed by specialised interventions considering the contextual residential settings and socio-economic factors highlighted in this study.
Article
Full-text available
Anemia is a common condition in pregnancy and has been associated with various adverse maternal and fetal outcomes. Hematological parameters are altered as a result of normal physiological changes during pregnancy, most notably a decrease in hemoglobin (Hb) concentration. As iron demands during pregnancy increases tremendously, it is not surprising that iron deficiency anemia is still the most common cause of anemia. Indeed, a mother's overall health and her ability to work can be negatively impacted by chronic iron deficiency, which also causes weariness. In order to assess the iron status, laboratory investigations are advised to start in the first trimester. Early identification and treatment of this clinical disease are essential because of the condition's severe negative effects on maternal-fetal outcomes. This calls for effective and immediate preventative measures to avoid further complications that may lead to maternal and fetal morbidity and mortality. This review serves as a brief to approach anemia in pregnancy. It provides an overview on understanding the problem and suggests recommendations to decrease the prevalence.
Article
Full-text available
Background: Anemia is a global public health problem that afects pregnant women. The most common cause of anemia is iron defciency which is extremely common in developing countries. World health organization reported that 36.5% of pregnant women are anemic globally. In Ethiopia, 27.08% of women of the reproductive age group are anemic. Therefore, this study aimed to identify the magnitude and factors associated with iron supplementation during pregnancy in the southern and eastern regions of Ethiopia. Methods: The data used in this analysis were extracted from Mini Demographic and Health Survey 2019. The survey was conducted in 9 regional states and two city administrations. The data used in the analysis were extracted from individual women datasets, and 1780 study participants were included in this study. The logistic regression analysis including bivariate and multivariable logistic regression at a 95% confdence interval and a p-value less than 0.05 was used. Result: The fnding of the study shows that iron supplementation during pregnancy in Southern and Eastern parts of Ethiopia was 50.06%. Among those who received iron, only about 20% took it for 90 days and more during their pregnancy. Iron supplementation among the pregnant women was afected by secondary education [AOR=2.20, 95%CI (1.325, 3.638)], residing in urban [AOR=1.75, 95%CI (1.192, 2.574)], having media at home [AOR =1.41, 95%CI (1.022, 1.946)], having antenatal care follow up [AOR =9.27, 95%CI (4.727, 18.169)], having 4 and more ANC follow up [AOR=2.01, 95%CI (1.468,2.760], having antenatal care follow up at government health institutions [AOR =3.40, 95%CI (1.934, 5.982)], and giving birth at governmental health institutions [AOR=1.70, 95%CI (1.236, 2.336)]. Conclusion: Only one in two pregnant women was supplemented with iron during their recent pregnancy. The supplementation was afected by women’s education, place of residence, presence of media at home, antenatal care follow-up, the number of antenatal care follow up, antenatal care follows up at governmental health institutions, and giving birth at the governmental health institution. The availability and accessibility of maternal care services and their functionality in providing maternal care services improve the supplementation.
Article
Full-text available
Background Anemia is a major public health concern among women of reproductive age leading to high maternal mortality in low- and middle-income countries. Of the prior studies conducted in Pakistan, most focused on large urban areas and did not explore the determinants of anemia among women of reproductive age (WRA) across socio-demographic, dietary, reproductive, and biological domains. Thus, we aimed to study the prevalence and determinants of anemia among WRA in rural Pakistan. Methods We conducted a cross-sectional study in the Thatta district of Pakistan from September 2018 to January 2019 and enrolled 150 non-pregnant, married women. Data collectors administered a structured questionnaire to collect sociodemographic, reproductive and dietary data from women, who also provided stool and blood samples. We classified all WRA as anemic if their hemoglobin was <12.0 g/dl. We performed logistic regression analysis to calculate adjusted odds ratios (aOR) and their respective 95% CIs to assess the determinants of anemia. Results In our study, 61.3% of the enrolled women were anemic. In the multivariable analysis, we found that factors such as serum iron levels of less than 50 μg/dl (aOR: 7.17; 95% CI (2.94, 17.47)), history of breastfeeding (aOR: 2.43; 95% CI (1.04, 5.72)), living in a katcha house (aOR: 6.61; 95% CI (2.21, 19.87)), no consumption of meat (aOR: 4.18; 95% CI (1.66, 9.96)) were significantly associated with anemia among WRA. A history of more than one abortion (aOR: 0.06; 95% CI (0.01, 0.33) appeared protective for its association with anemia. Conclusion Our findings demonstrate a high burden of anemia and its complex determinants among WRA in rural Pakistan. A combination of nutritional and educational strategies should be designed to encourage rural women to consume iron-rich foods in their diet with an access to adequate food. Breastfeeding women should be encouraged to consume extra calories with sufficient intake of the food to continue exclusive breastfeeding and reserve the iron stores through amenorrhea to prevent themselves from becoming anemic.
Article
Özet:Anemi, gebelikte en yaygın hemotolojik bir sorundur. Dünyadaki gebe kadınların %38.2'sinin anemik olduğu, tahmin edilmektedir. Türkiye’de üreme çağındaki kadınlarda anemi sıklığının %20 ile %39.9 arasında değiştiği belirtilmektedir. Gebelik dönemindeki anemiler edinsel ve kalıtsal olmak üzere iki grupta değerlendirilir. Gebelikte sıklıkla edinsel yetmezlik anemilerinden olan demir eksikliği ve daha az sıklıkla da folik asit eksikliği anemisi oluşur. Demir eksikliği anemisi (DEA)’nin en temel nedeni; gebelik öncesinde demir düzeyinin düşüklüğü, gebelikte absorbsiyonun artması ile artan gereksinimdir. Demir eksikliği anemisinin tanısı için öncelikle hemoglobin (Hb) ve serum ferritin düzeyi ölçülür. Gebelikte en düşük Hb değeri 1. ve 3. trimesterde <11 gr/dL, 2. trimesterde <10,5 gr/dL’olmalıdır. Gebelikte anemi; annenin hastalanma ve ölüm riskinde artışla (%20-40 oranında), fetüste ise intrauterin büyüme geriliği, düşük doğum ağırlığı, erken doğum ve perinatal mortalite riskinde artışla ilişkilidir. Maternal ve fetal komplikasyonların önlenmesi için gebe kadınlara demir ve folat desteği verilmesi önemlidir. Demir eksikliği anemisinde oral demir tedavisi birinci basamak tedavi olarak verilir. Oral tedavi yanıtsızlığı, tedaviye uyum sorunu, çok düşük hemoglobin değerleri ve hızlı demir replasmanına ihtiyaç duyulması gibi durumlarda intravenoz (İV) demir tedavisi tercih edilmektedir. Bu derlemede gebelikte demir ve folat eksikliği anemisinde kanıta dayalı güncel yaklaşımların incelenmesi amaçlanmıştır.
Article
Full-text available
Iron deficiency is the most common deficiency state in the world, affecting more than 2 billion people globally. Although it is particularly prevalent in less-developed countries, it remains a significant problem in the developed world, even where other forms of malnutrition have already been almost eliminated. Effective management is needed to prevent adverse maternal and pregnancy outcomes, including the need for red cell transfusion. The objective of this guideline is to provide healthcare professionals with clear and simple recommendations for the diagnosis, treatment and prevention of iron deficiency in pregnancy and the postpartum period. This is the first such guideline in the UK and may be applicable to other developed countries. Public health measures, such as helminth control and iron fortification of foods, which can be important to developing countries, are not considered here. The guidance may not be appropriate to all patients and individual patient circumstances may dictate an alternative approach.
Article
Full-text available
This review focuses on the occurrence, prevention and treatment of anaemia during pregnancy in Western societies. Iron deficiency anaemia (IDA) is the most prevalent deficiency disorder and the most frequent form of anaemia in pregnant women. Minor causes of anaemia are folate and vitamin B12 deficiency, haemoglobinopathy and haemolytic anaemia. Anaemia is defined as haemoglobin of <110 g/L in the first and third trimester and <105 g/L in the second trimester. The diagnosis relies on haemoglobin, a full blood count and plasma ferritin, which can be supported by plasma transferrin saturation and serum soluble transferrin receptor. Among fertile, non-pregnant women, approximately 40% have ferritin of <or=30 microg/L, i.e. small or absent iron reserves and therefore an unfavourable iron status with respect to upcoming pregnancy. The prevalence of prepartum anaemia in the third trimester ranges 14-52% in women taking placebo and 0-25% in women taking iron supplements, dependent on the doses of iron. In studies incorporating serum ferritin, the frequency of IDA in placebo-treated women ranges 12-17% and in iron-supplemented women 0-3%. Requirements for absorbed iron increase during pregnancy from 0.8 mg/day in the first trimester to 7.5 mg/day in the third trimester, on the average approximately 4.4 mg/day, and dietary measures are inadequate to reduce the frequency of prepartum IDA. However, IDA is efficiently prevented by oral iron supplements in doses of 30-40 mg ferrous iron taken between meals from early pregnancy to delivery. Treatment of IDA should aim at replenishing body iron deficits by oral and/or intravenous administration of iron. In women with slight to moderate IDA, i.e. haemoglobin of 90-105 g/L, treatment with oral ferrous iron of approximately 100 mg/day between meals is the therapeutic option in the first and second trimester; haemoglobin should be checked after 2 weeks and provided an increase of >or=10 g/L, oral iron therapy has proved effective and should continue. Treatment with intravenous iron is superior to oral iron with respect to the haematological response. Intravenous iron is considered safe in the second and third trimester, while there is little experience in the first trimester. Intravenous iron of 600-1,200 mg should be considered: (1) as second option if oral iron fails to increase haemoglobin within 2 weeks; (2) as first option at profound IDA, i.e. haemoglobin of <90 g/L in any trimester beyond 14 weeks gestation; and (3) as first option for IDA in third trimester. Profound IDA has serious consequences for both woman and foetus and requires prompt intervention with intravenous iron. This is especially important for the safety of women who for various reasons oppose blood transfusions.
Article
Full-text available
• Iron deficiency anaemia (IDA) remains prevalent in Australia and worldwide, especially among high‐risk groups. • IDA may be effectively diagnosed in most cases by full blood examination and serum ferritin level. Serum iron levels should not be used to diagnose iron deficiency. • Although iron deficiency may be due to physiological demands in growing children, adolescents and pregnant women, the underlying cause(s) should be sought. • Patients without a clear physiological explanation for iron deficiency (especially men and postmenopausal women) should be evaluated by gastroscopy/colonoscopy to exclude a source of gastrointestinal bleeding, particularly a malignant lesion. • Patients with IDA should be assessed for coeliac disease. • Oral iron therapy, in appropriate doses and for a sufficient duration, is an effective first‐line strategy for most patients. • In selected patients for whom intravenous (IV) iron therapy is indicated, current formulations can be safely administered in outpatient treatment centres and are relatively inexpensive. • Red cell transfusion is inappropriate therapy for IDA unless an immediate increase in oxygen delivery is required, such as when the patient is experiencing end‐organ compromise (eg, angina pectoris or cardiac failure), or IDA is complicated by serious, acute ongoing bleeding. • Consensus methods for administration of available IV iron products are needed to improve the utilisation of these formulations in Australia and reduce inappropriate transfusion. • New‐generation IV products, supported by high‐quality evidence of safety and efficacy, may facilitate rapid administration of higher doses of iron, and may make it easier to integrate IV iron replacement into routine care.
Article
Full-text available
The review focuses on iron balance during pregnancy and postpartum in the Western affluent societies. Iron status and body iron can be monitored using serum ferritin, haemoglobin, serum soluble transferrin receptors (sTfR) and the sTfR/ferritin ratio. Requirements for absorbed iron increase during pregnancy from 0.8 mg/day in the first trimester to 7.5 mg/day in the third trimester. Average requirement during the entire gestation is approximately 4.4 mg/day. Intestinal iron absorption increases during pregnancy, but women with ample body iron reserves have lower absorption than those with depleted reserves, so increased absorption is, in part, due to progressive iron depletion. Apparently, women do not change dietary habits when they become pregnant. Non-pregnant Scandinavian women have a median dietary iron intake of approximately 9 mg/day, i.e. more than 90% of the women have an intake below the recommended approximately 18 mg/day. Non-pregnant women have a low iron status, 42% have serum ferritin levels <or=30 microg/l, i.e. small or depleted iron reserves and 2-4% have iron deficiency anaemia; only 14-20% have ferritin levels >70 microg/l corresponding to body iron of >or=500 mg. The association between high haemoglobin during gestation and a low birth weight of the newborns is caused by inappropriate haemodilution. In placebo-controlled studies on healthy pregnant women, there is no relationship between the women's haemoglobin and birth weight of the newborns and no increased frequency of preeclampsia in women taking iron supplements.
Article
Anemia during pregnancy and the postpartum period is commonly caused by iron deficiency and is a significant worldwide issue with severe consequences for both mother and developing fetus. From a worldwide perspective, iron-deficiency anemia (IDA) during pregnancy is highest in the Asia-Pacific region; however, there has been little guidance in this region for safe and effective treatment. An expert panel was convened to develop a concise and informative set of recommendations for the treatment of IDA in pregnant and postpartum women in the Asia-Pacific region. This manuscript provides these recommendations and aims to reduce the morbidity and mortality associated with IDA in pregnant and postpartum women in the Asia-Pacific region. The consensus recommendations define anemia as a hemoglobin (Hb) level <10.5 g/dL during pregnancy and <10 g/dL during the postpartum period, and provide cut-off Hb levels to initiate therapy with oral iron, intravenous iron or red blood cell transfusion.
Centres for Disease Control and Prevention. Recommendations to Prevent and Control Iron Deficiency in the United States
Centres for Disease Control and Prevention. Recommendations to Prevent and Control Iron Deficiency in the United States. Morbidity and Mortality weekly Report. 1998;47(No. RR-3)
Prepartum anaemia: prevention and treatment Reveiz l, Gyte GMI, Cuervo lG. Treatments for iron-deficiency anaemia in pregnancy. The Cochrane Database of Systematic reviews
  • N Milman
Milman N. Prepartum anaemia: prevention and treatment. Annals of Haematology. 2008;87:949-59. 4. Reveiz l, Gyte GMI, Cuervo lG. Treatments for iron-deficiency anaemia in pregnancy. The Cochrane Database of Systematic reviews. 2007(2).
Obstetrics and Gynaecology An evidence-based text for MRCOG 2nd ed. london: Hodder Arnold
  • Johnson Ta Anaemia
Johnson TA. Anaemia. In: Luesley DM, Baker PN, editors. Obstetrics and Gynaecology An evidence-based text for MRCOG 2nd ed. london: Hodder Arnold; 2010;139-43.